Boston, MA -- (SBWIRE) -- 10/01/2015 -- Cephalosporins are bactericidal antibiotics and act by inhibiting cell wall synthesis. They inhibit a wide variety of gram-positive and gram-negative bacteria. They are considered broad-spectrum antibiotics with similar activities to those of ampicillin. They are sometimes grouped into "generations" by their antimicrobial properties. Cephalosporin drugs can be grouped into five classes or generations. The gram-negative antimicrobial property significantly increases with each newer generation of cephalosporin.

Technavio's analysts forecast the global cephalosporin drugs market to grow at a CAGR of 3.21% over the period 2014-2019.

Covered in this report
In this report, Technavio covers the present scenario and growth prospects of the global cephalosporin drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various prescription drugs along with the generic drugs used for the treatment of various infectious diseases caused by the different strains of bacteria.

Get More Details on this Report and a Full Table of Contents at Global Cephalosporin Drugs Market 2015-2019

Technavio's report, Global Cephalosporin Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global cephalosporin drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

-Americas
-APAC
-EMEA

Key vendors

-Allergan
-Astellas
-Bristol-Myers Squibb
-GlaxoSmithKline
-Merck
-Pfizer
-Sandoz
-Teva Pharmaceuticals

Other prominent vendors

-Abbott
-Aspen Pharmacare
-AstraZeneca
-Aurobindo Pharma
-Basilea Pharmaceuticals
-Baxter
-Biocon
-Corden Pharma
-Cornerstone Therapeutics
-Eli Lilly
-F. Hoffmann-La Roche
-Flynn Pharma
-Hospira
-Incepta Pharmaceuticals
-Johnson & Johnson
-Kyorin Pharmaceutical
-Lupin Pharmaceuticals
-Orchid Pharma
-Par Pharmaceutical
-Pernix Therapeutics
-Sanofi
-Shionogi
-Sun Pharmaceutical
-Takeda Pharma
-Theravance Biopharma
-Wockhardt

Market driver

-Special regulatory designation for pipeline molecules
-For a full, detailed list, view our report

Market challenge

-Development of drug resistance
-For a full, detailed list, view our report

Market trend

-Use of combination therapies
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2019 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

Companies Mentioned in this Report: Allergan, Astellas, Bristol-Myers Squibb, GSK, Merck, Pfizer, Sandoz, Teva, Abbott, Aspen Pharmacare, AstraZeneca, Aurobindo Pharma, Basilea Pharmaceuticals, Baxter, Biocon, Corden Pharma, Eli Lilly, F. Hoffmann-La Roche, Flynn Pharma, Hospira, Incepta Pharmaceuticals, Johnson & Johnson, Kyorin Pharmaceutical, Lupin Pharmaceuticals, Orchid Pharma, Par Pharmaceutical, Pernix Therapeutics, Sanofi, Shionogi, Sun Pharmaceutical, Takeda Pharma, Theravance Biopharma, Wockhardt.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Global Fibromyalgia Drugs Market 2015-2019
-Global Colorectal Cancer Drugs Market 2015-2019
-PharmaPoint: Glaucoma - Global Drug Forecast and Market Analysis to 2023
-Global Gastrointestinal OTC Drugs Market 2015-2019
-Global Chronic Kidney Disease (CKD) Drugs Market 2015-2019